Incyte Data to Be Highlighted in Four Rapid Oral Presentations at the European Society for Medical Oncology (ESMO) Congress 2026 Support Efforts to Improve Outcomes in Difficult-to-Treat Cancers
Go back to Incyte Data to Be Highlighted in Four Rapid Oral Presentations at the European Society for Medical Oncology (ESMO) Congress 2026 Support Efforts to Improve Outcomes in Difficult-to-Treat Cancers| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 117.67 +0.98 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $116.69 | 52 Week High | $118.49 | |||
| Open | $117.71 | 52 Week Low | $55.00 | |||
| Day High | $119.13 | P/E | N/A | |||
| Day Low | $116.70 | EPS | $-0.56 | |||
| Volume | 1,206,904 | |||||
